Here, we describe the clinical and pathological features of a cluster of families that share the private c.709-1G>A GRN mutation for FTLD and the p.A152T MAPT variant, which has been identified as a risk factor for AD and FTD-spectrum disorders. Here, MAPT is linked to Alzheimer disease.